Results 31 to 40 of about 91,961 (167)

Impact of Pre‐Heart Transplant Levosimendan Administration on Post‐Transplant Vasoplegia and Primary Graft Dysfunction

open access: yesClinical Transplantation, Volume 39, Issue 10, October 2025.
ABSTRACT Introduction Levosimendan, a calcium‐sensitizing inotropic agent, is used in patients with advanced heart failure (HF) awaiting heart transplantation (HT). Its prolonged effects, due to an active metabolite, may influence post‐transplant vasodilation, particularly when administered shortly before HT.
Joan Guzman‐Bofarull   +9 more
wiley   +1 more source

Prevalence of NANDA‐I Nursing Diagnoses in patients with heart failure: A systematic review and meta‐analysis

open access: yesInternational Journal of Nursing Knowledge, Volume 36, Issue 1, Page 106-119, January 2025.
Abstract Aim This research quantitatively explored the prevalence of NANDA‐I nursing diagnoses related to the care of patients experiencing heart failure. Design A systematic review and meta‐analysis were conducted with the systematic review protocol registered in PROSPERO (registration number: CRD42022382565).
Inmaculada Paneque‐Sánchez‐Toscano   +3 more
wiley   +1 more source

Reciprocal Abstracts July 2023

open access: yes, 2023
Hong Kong Journal of Emergency Medicine, Volume 30, Issue 4, Page 261-265, July 2023.
wiley   +1 more source

Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction

open access: yesEuropean Journal of Heart Failure, Volume 26, Issue 8, Page 1788-1803, August 2024.
Regions, characteristics and clinical outcomes in patients with heart failure (HF) with mildly reduced (HFmrEF) and preserved ejection fraction (HFpEF). (A) Map showing the distribution of patients of the trials included. Cardiovascular (CV) death and first HF hospitalization events in patients with HFmrEF (B) and with HFpEF (C). AP, Asia‐Pacific; CEER,
Mingming Yang   +21 more
wiley   +1 more source

Reciprocal Abstracts January 2023

open access: yes, 2023
Hong Kong Journal of Emergency Medicine, Volume 30, Issue 1, Page 65-68, January 2023.
wiley   +1 more source

Nuevos farmacos en insuficiencia cardíaca

open access: yes, 2001
La insuficiencia cardíaca es un problema de salud pública importante que ha tenido un incremento significativo en incidencia y prevalencia en las dos últimas décadas.
de Marchena, Eduardo   +2 more
core   +1 more source

Angiosarcoma cardíaco: una causa rara de insuficiencia cardíaca [PDF]

open access: yes, 2022
RESUMEN Se presenta el caso de un hombre, de 76 años, con un angiosarcoma cardíaco que debutó con insuficiencia cardíaca y taponamiento pericárdico. Se trata de un tumor muy raro, esto hace que el diagnóstico sea difícil y en ocasiones tardío.
Ramos-Díaz,Celia   +2 more
core   +1 more source

Concepto de insuficiencia cardíaca [PDF]

open access: yes, 1988
Se define el concepto clínico de insuficiencia cardíaca. Se describe la flsíopatología así como los distintos mecanismos que intentan compensar el corazón afectado, analizando fmalmente los signos clínicos que nos vamos a encontrar y de esta manera ...
Closa, Josep Maria   +3 more
core   +1 more source

Combined cardiorenal transplant in heart and advanced renal disease

open access: yesRevista de Nefrología, Diálisis y Trasplante, 2017
Introduction: Renal failure (RF) is a post cardiac transplantation predictor of morbimortality. The combined cardiorenal transplant (CCRTx) in cardiac transplantation (CTx) candidates with chronic renal disease is a therapeutic option.
Margarita Peradejordi Lastras   +12 more
doaj  

Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial‐IRON trial

open access: yesESC Heart Failure, Volume 11, Issue 2, Page 1258-1262, April 2024.
Abstract Aims Iron deficiency (ID) is associated with an impaired cardiac function and remodelling in heart failure (HF). Treatment with ferric carboxymaltose (FCM) has been showed recently to improve biventricular systolic function and ventricular strain parameters in patients with HF with reduced ejection fraction and ID, but there is no evidence on ...
Enrique Santas   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy